Sogo Medical Co. Ltd. said its normalized net income for the fiscal fourth quarter ended March 31 amounted to ¥97.05 per share, an increase of 15.0% from ¥84.43 per share in the year-earlier period.

Normalized net income, which excludes unusual gains or losses on a pre- and after-tax basis, was ¥1.40 billion, a gain of 15.0% from ¥1.22 billion in the prior-year period.

The normalized profit margin rose to 4.8% from 4.2% in the year-earlier period.

Total revenue totaled ¥28.93 billion, compared with ¥28.83 billion in the year-earlier period, and total operating expenses totaled ¥26.74 billion, compared with ¥26.88 billion in the prior-year period.

Reported net income came to ¥1.12 billion, or ¥77.30 per share, compared to ¥1.11 billion, or ¥76.60 per share, in the prior-year period.

For the year, the company's normalized net income totaled ¥226.92 per share, a gain from ¥219.20 per share in the prior year.

Normalized net income was ¥3.28 billion, an increase from ¥3.16 billion in the prior year.

Full-year total revenue grew year over year to ¥107.94 billion from ¥103.32 billion, and total operating expenses increased year over year to ¥102.93 billion from ¥98.30 billion.

The company said reported net income decreased year over year to ¥2.77 billion, or ¥192.13 per share, in the full year, from ¥2.86 billion, or ¥197.81 per share.

As of June 19, US$1 was equivalent to ¥122.78.